Drugs@FDA document
VESICARE Pediatric Clinical Pharmacology Review · NDA 021518 ORIG-1
Drugs@FDA document · ASTELLAS · Jul 20, 2017
Key facts
| Drug name | VESICARE |
|---|---|
| Document type | Pediatric Clinical Pharmacology Review |
| Application | NDA021518 |
| Submission | ORIG-1 |
| Company | ASTELLAS |
| Document date | Jul 20, 2017 |
At a glance
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: